Answers are grounded in this paper and cite their sources.
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
No takes yet. Share an insight, caveat, or question.
Koong et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: